Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-inferiority, Phase IV, Open-label, Randomized Controlled Trial of Vesical Imaging- Reporting and Data System (VI-RADS) Followed by Primary Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) Versus Conventional White-light TURBT Plus Repeated-TURBT (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) Candidate for Second Look and Resection

NCT05962541 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT05962541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05962541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-inferiority, Phase IV, Open-label, Randomized Controlled Trial of Vesical Imaging- Reporting and Data System (VI-RADS) Followed by Primary Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) Versus Conventional White-light TURBT Plus Repeated-TURBT (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) Candidate for Second Look and Resection
Lead sponsor
University of Roma La Sapienza
Phase
Phase 4
Overall status
Recruiting
Start date
December 22, 2025
Completion date
December 31, 2031
Enrollment
327 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high risk non-muscle invasive bladder urothelial carcinoma, non-muscle invasive bladder urothelial carcinoma, non-muscle-invasive bladder cancer